Comparative effectiveness of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with de novo heart failure with mildly reduced and preserved ejection fraction

被引：1
|
作者：
Bhatt, Ankeet S. [1 ,2 ,3 ]
Vaduganathan, Muthiah [4 ]
Jena, Barada Prasad [5 ]
Suminska, Sylwia [6 ]
Eid, Carlos [7 ]
Khairnar, Rahul [8 ]
Farries, Gabriella [6 ]
Senni, Michele [9 ]
机构：
[1] Kaiser Permanente San Francisco Med Ctr, San Francisco, CA USA
[2] Div Res, San Francisco, CA USA
[3] Stanford Univ, Sch Med, Div Cardiovasc Med, Palo Alto, CA USA
[4] Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA USA
[5] Novartis Global Serv Ctr, Hyderabad, India
[6] Novartis Corp Ctr, Dublin, Ireland
[7] Novartis Pharm Serv AG, Off Middle East & North Afr, Nairobi, Kenya
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Univ Milano Bicocca, Osped Papa Giovanni XXIII, Bergamo, Italy
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷 / 05期
关键词：
D O I：
10.1002/ejhf.3233
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1172 / 1174
页数：3
相关论文
共 50 条
  • [1] Comparative effectiveness of sacubitril/valsartan versus angiotensin converting enzyme inhibitors/angiotensin receptor blockers in de novo heart failure patients
    Taha, I.
    Gomme, J.
    Suminska, S.
    Schwende, H.
    Butylin, D.
    Doherty, J.
    Beckmeyer-Borowko, A.
    Farries, G.
    EUROPEAN HEART JOURNAL, 2022, 43 : 979 - 979
  • [2] COMPARATIVE EFFECTIVENESS AND COSTS OF SACUBITRIL/VALSARTAN VERSUS ANGIOTENSIN RECEPTOR BLOCKERS IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Riaz, M.
    Smith, S.
    Winchester, D. E.
    Guo, J.
    Dietrich, E.
    Park, H.
    VALUE IN HEALTH, 2023, 26 (06) : S40 - S40
  • [3] Hospitalization Rates in Patients with Heart Failure and Reduced Ejection Fraction Initiating Sacubitril/Valsartan or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: A Retrospective Cohort Study
    Emma Houchen
    Emil Loefroth
    Raymond Schlienger
    Clare Proudfoot
    Stefano Corda
    Sibasish Saha
    Sarvesh K. Satwase
    Rachel Studer
    Cardiology and Therapy, 2022, 11 : 113 - 127
  • [4] Hospitalization Rates in Patients with Heart Failure and Reduced Ejection Fraction Initiating Sacubitril/Valsartan or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: A Retrospective Cohort Study
    Houchen, Emma
    Loefroth, Emil
    Schlienger, Raymond
    Proudfoot, Clare
    Corda, Stefano
    Saha, Sibasish
    Satwase, Sarvesh K.
    Studer, Rachel
    CARDIOLOGY AND THERAPY, 2022, 11 (01) : 113 - 127
  • [5] Cost-Effectiveness of Sacubitril-Valsartan Compared to Angiotensin-Converting Enzyme Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction
    Febrinasari, Ratih P.
    Putra, Stefanus E.
    Hafizhan, Muhammad
    Probandari, Ari N.
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (04) : 915 - 924
  • [6] Comparative effectiveness of sacubitril/valsartan versus angiotensin receptor blockers in patients with heart failure with preserved ejection fraction: A real-world study
    Riaz, Munaza
    Smith, Steven M.
    Dietrich, Eric A.
    Winchester, David E.
    Guo, Jingchuan
    Park, Haesuk
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (14) : 599 - 607
  • [7] Impact of prolonged use of angiotensin receptor-neprilysin inhibitors versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with heart failure reduced ejection fraction
    Jang, S. Y.
    Park, H. K.
    Park, B. E.
    Jung, M. S.
    Yang, D. H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 61 - 61
  • [8] Timing of prescription of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients hospitalized for acute heart failure with reduced/mildly reduced ejection fraction: a retrospective analysis
    Ishii, Tsuyoshi
    Matsue, Yuya
    Matsunaga, Yuki
    Iekushi, Kazuma
    Homma, Yuji
    Morita, Yohei
    HEART AND VESSELS, 2024, 39 (01) : 25 - 34
  • [9] Timing of prescription of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients hospitalized for acute heart failure with reduced/mildly reduced ejection fraction: a retrospective analysis
    Tsuyoshi Ishii
    Yuya Matsue
    Yuki Matsunaga
    Kazuma Iekushi
    Yuji Homma
    Yohei Morita
    Heart and Vessels, 2024, 39 : 25 - 34
  • [10] COMPARATIVE EFFECTIVENESS OF SACUBITRIL-VALSARTAN VERSUS ANGIOTENSIN CONVERTING ENZYME INHIBITORS / ANGIOTENSIN RECEPTOR BLOCKERS THERAPY ON RENAL OUTCOMES IN SYSTOLIC HEART FAILURE PATIENTS
    Deng, Y.
    Tan, N. Y.
    Yao, X.
    Sangaralingham, L.
    Shah, N. D.
    Rule, A. D.
    Burnett, J. C.
    Dunlay, S. M.
    Sangaralingham, S. J.
    VALUE IN HEALTH, 2020, 23 : S92 - S92
12345